cover
Contact Name
Eka Deviany Widyawaty
Contact Email
renacipta49@gmail.com
Phone
+6282233325390
Journal Mail Official
renacipta49@gmail.com
Editorial Address
Puri Kartika Asri Arjowinangun Kedung Kandang Kota Malang
Location
Kota malang,
Jawa timur
INDONESIA
Jurnal Medicare
Published by Rena Cipta Mandiri
ISSN : -     EISSN : 2828352X     DOI : -
Core Subject : Health,
Medicare Journal, ISSN 2828-352X (media online) contains writings taken from the results of research in obstetrics and nursing, pregnancy, childbirth, postpartum; baby; family plans; reproduction health; complementary midwifery care. This journal is published four times a year. Medicare Journal is published by CV. Rena Cipta Mandiri Malang City. Publication schedule: January, April, July, October
Articles 331 Documents
Profile of Irregular Antibodies in Multiparous Pregnant Women and Its Implications for Maternal Transfusion Services at Gotong Royong Hospital, Surabaya Wiwid Salsulhadi Kesehatan; Yustisia Amalia Kesehatan; Miftahul Khairoh
Jurnal Medicare Vol. 5 No. 3 (2026): JULY 2026 (INPRESS)
Publisher : Rena Cipta Mandiri

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62354/jurnalmedicare.v5i3.588

Abstract

Background: Multiparous pregnancy increases maternal exposure to fetal red blood cell antigens that differ from maternal antigens, potentially triggering the formation of irregular antibodies. These antibodies have implications for maternal transfusion safety because they may complicate the selection of compatible blood and increase the risk of transfusion reactions and hemolytic disease in the fetus or newborn. Objective: This study aimed to identify the profile of irregular antibodies in multiparous pregnant women and analyze their implications for maternal blood transfusion services at Gotong Royong Hospital, Surabaya. Methods: This study employed a descriptive observational design with a cross-sectional approach. The subjects were multiparous pregnant women undergoing antenatal examinations. Laboratory examinations included ABO and Rhesus blood grouping, irregular antibody screening, and antibody identification in samples with positive screening results. Maternal characteristics, parity, transfusion history, and pregnancy history were analyzed descriptively. Results: Variations were found in the results of irregular antibody screening. The identified antibodies were evaluated based on their clinical significance for blood compatibility. Multiparity and a history of blood transfusion were important factors in pre-transfusion evaluation. Conclusion: Screening and identification of irregular antibodies are important to support the selection of compatible blood and improve the safety of maternal transfusion services.